Pear Therapeutics, Inc.

200 State Street, 13th Floor

Boston, MA 02109

January 6, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re:         Pear Therapeutics, Inc.

Registration Statement on Form S-3

File No. 333-269097

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Pear Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-269097) (the “Registration Statement”), so that it may become effective at 4:00 pm Eastern time on January 10, 2023, or as soon thereafter as practicable, or at such other time as the Registrant or its outside counsel, Foley Hoag LLP, requests by telephone that such Registration Statement be declared effective.

Please feel free to direct any questions or comments concerning this request to Stacie S. Aarestad, Esq. of Foley Hoag LLP at (617) 832-1108.

[Remainder of this page intentionally left blank]

Very truly yours,
PEAR THERAPEUTICS, INC.
By:	/s/ Corey McCann
	Name: Corey McCann Title: President and Chief Executive Officer

[Signature Page to Pear Therapeutics, Inc. Acceleration Request]